AChE |
Acetylcholinesterase |
AhR |
Aryl Hydrocarbon Receptor |
AMH |
Anti-Müllerian hormone |
BALF |
Bronchoalveolar Lavage Fluid |
BMI |
Body Mass Index |
CEC |
Contaminants of Emerging Concern |
CNS |
Central Nervous System |
2,8-DCDD |
2,8-dichlorodibenzo-p-dioxin |
2,4-DCP |
2,4-Dichlorophenol |
EDCs |
Endocrine Disrupting Chemicals |
EDTA |
Ethylenediaminetetraacetic Acid |
ENR |
Enoyl-acyl carrier Protein Reductase |
EU |
European Union |
FASN |
Fatty Acid Synthase Inhibitor |
FDA |
Food and Drug Administration |
FSH |
Follicle-stimulating hormone |
FT3 |
Triiodothyronine |
FT4 |
Thyroxine |
GOT |
Glutamic Oxaloacetic Transaminase |
GPT |
Glutamic Pyruvic Transaminase |
HCC |
Hepatocellular Carcinoma |
HOME |
Health Outcomes and Measures of the Environment |
HUVEC |
Human Umbilical Vein Endothelial Cell |
IC50
|
Half Minimal Inhibitory Concentration |
IgE |
Immunoglobulin E |
IL-6 |
Interleukin-6 |
LU |
Luteinizing hormone |
LPS |
Lipopolysaccharide |
MIC |
Minimum Inhibitory Concentration |
MTCS |
Methyltriclosan |
NHANES |
National Health and Nutrition Examination Surveys |
OTC |
Over-the-counter |
PCOS |
Polycystic Ovary Syndrome |
PPCPs |
Pharmaceutical and Personal Care Products |
PVM/MA |
Polyvinylmethyl Ether Maleic Acid |
REACH |
Registration, Evaluation, Authorisation and Restriction of Chemicals |
ROS |
Reactive Oxygen Species |
SHIME |
Simulator of the Human Intestinal Microbial Ecosystem |
SSIs |
Surgical Site Infections |
TCC |
Triclocarban |
TCS |
Triclosan |
TNF-α |
Tumor Necrosis Factor alpha |
TP |
Total Protein |
TSH |
Thyroid-stimulating hormone |
UDP |
Uridine diphosphate |
UGTs |
UDP-glucuronosyltransferases |